We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Promising Preclinical Results for Compound to Treat Wilson's Disease

News   Jun 28, 2018 | Original story from Cold Spring Harbor Laboratory (CSHL)

 
Promising Preclinical Results for Compound to Treat Wilson's Disease

Liver complications in Wilson's disease include enlarged cell size, irregular shape and arrangement in liver tissue (left image). Treatment with DPM-1001 reversed these pathologies in a Wilson's disease mouse model (right image) and led to dramatic lowering of tissue copper levels. Credit: Tonks Lab, CSHL

 
 
 

RELATED ARTICLES

Heart Attack Modeled With Human Stem Cells

News

Researchers have modeled myocardial infarction using human stem cells, which may provide a useful platform for drug development without the need for sacrificing animals.

READ MORE

A New Treatment Approach for Type 2 Diabetes?

News

The protein adipsin helps protect insulin-secreting cells called pancreatic beta cells from destruction in Type 2 diabetes, according to a new research.

READ MORE

Common Muscle Relaxant Causes Confusion in Patients With Kidney Disease

News

A new study indicates that patients with kidney dysfunction who were prescribed a high dose of the drug baclofen, were more likely to be admitted to hospital for disorientation and confusion, than those who were not prescribed the drug.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE